Literature DB >> 114290

Changes in proline synthetic and degradative enzymes during matrix-induced cartilage and bone formation.

R J Smith, A H Reddi, J M Phang.   

Abstract

Proline biosynthetic and degradative enzymes are unevenly distributed in differentiated mammalian tissues. Activities of the synthetic enzymes are relatively high in collagenous tissues, whereas activities of the degradative enzymes are high in noncollagenous tissues. In order to further characterize tissue-specific proline biosynthesis and degradation, we have determined proline enzyme activities during cartilage and bone formation induced by demineralized bone matrix. We can thus follow temporal changes in enzyme activity in a single tissue as different cell types develop. Ornithine aminotransferase and pyrroline-5-carboxylate reductase have peaks of activity which correlate with maximal type II collagen synthesis by chondrocytes. Both enzymes also are active during bone formation. In contrast, proline oxidase and pyrroline-5-carboxylate dehydrogenase are present at low levels and do not change as new cell types appear. Arginase activity peaks during the first 3 days and then rapidly decreases by the time cartilage and bone formation begin. These observations further substantiate the importance of proline biosynthesis in collagenous tissues. The close correlation between ornithine aminotransferase activity and type II collagen synthesis suggests that the pathway from ornithine to proline may be especially important during formation of type II collagen.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 114290     DOI: 10.1007/bf02441197

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  14 in total

1.  Adaptive characteristics of urea cycle enzymes in the rat.

Authors:  R T SCHIMKE
Journal:  J Biol Chem       Date:  1962-02       Impact factor: 5.157

2.  A radioisotopic assay for proline oxidase activity.

Authors:  J M Phang; S J Downing; D L Valle; E M Kowaloff
Journal:  J Lab Clin Med       Date:  1975-02

3.  Changes in ornithine decarboxylase activity during matrix-induced cartilage, bone and bone marrow differentiation.

Authors:  N C Rath; A H Reddi
Journal:  Biochem Biophys Res Commun       Date:  1978-03-15       Impact factor: 3.575

4.  Biochemical sequences in the transformation of normal fibroblasts in adolescent rats.

Authors:  A H Reddi; C Huggins
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

5.  A radioisotopic assay for ornithine-delta-transaminase.

Authors:  J M Phang; S J Downing; D Valle
Journal:  Anal Biochem       Date:  1973-09       Impact factor: 3.365

6.  A radioisotopic assay for delta1-pyrroline-5-carboxylate reductase.

Authors:  J M Phang; S J Downing; D Valle
Journal:  Anal Biochem       Date:  1973-09       Impact factor: 3.365

Review 7.  Metabolism of proline and of hydroxyproline.

Authors:  E Adams
Journal:  Int Rev Connect Tissue Res       Date:  1970

8.  Proline metabolism in cartilage: the importance of proline biosynthesis.

Authors:  R J Smith; J M Phang
Journal:  Metabolism       Date:  1978-06       Impact factor: 8.694

9.  Type 2 hyperprolinemia: absence of delta1-pyrroline-5-carboxylic acid dehydrogenase activity.

Authors:  D L Valle; J M Phang; S I Goodman
Journal:  Science       Date:  1974-09-20       Impact factor: 47.728

10.  Collagenous bone matrix-induced endochondral ossification hemopoiesis.

Authors:  A H Reddi; W A Anderson
Journal:  J Cell Biol       Date:  1976-06       Impact factor: 10.539

View more
  2 in total

1.  Changes in lipids during matrix: induced endochondral bone formation.

Authors:  A L Boskey; A H Reddi
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

2.  Compartmentalization of proline pools and apparent rates of collagen and non-collagen protein synthesis in arterial smooth muscle cells in culture.

Authors:  W P Opsahl; L A Ehrhart
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.